Paper · 39205477
The Role of Microvascular Variations in the Process of Intervertebral Disk Degeneration and Its Regulatory Mechanisms: A Literature Review.
Zhang SP and 7 others. Orthop Surg, 2024. Cited by 10 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Role of Microvascular Variations in the Process of Intervertebral Disk Degeneration and Its Regulatory Mechanisms: A Literature Review. Papers, record 39205477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39205477
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Role of Microvascular Variations in the Process of Intervertebral Disk Degeneration and Its Regulatory Mechanisms: A Literature Review.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Intervertebral Disc Degeneration | Major topic |
| Microvessels | Major topic |
| Humans | |
| Neovascularization, Pathologic |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022TSYCLJ0027 | Science and technology Innovation Leading Talents Program - high-level leading talents | PubMed | ||
| 2022B03011-1 | Key Research and Development Program of Xinjiang Uygur Autonomous Region | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References123
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37,483,952 | Intervertebral disc degeneration-Current therapeutic options and challenges. | Front Public Health | 2023 | https://conductscience.org/library/papers/37483952 | PubMed |
| 2 | 23,664,860 | Stanniocalcin-1 and -2 promote angiogenic sprouting in HUVECs via VEGF/VEGFR2 and angiopoietin signaling pathways. | Mol Cell Endocrinol | 2013 | https://conductscience.org/library/papers/23664860 | PubMed |
| 3 | 37,809,657 | IL-1β-mediated inflammatory responses in intervertebral disc degeneration: Mechanisms, signaling pathways, and therapeutic potential. | Heliyon | 2023 | https://conductscience.org/library/papers/37809657 | PubMed |
| 4 | 34,812,197 | Dynamic Pressure Stimulation Upregulates Collagen II and Aggrecan in Nucleus Pulposus Cells Through Calcium Signaling. | Spine (Phila Pa 1976) | 2022 | https://conductscience.org/library/papers/34812197 | PubMed |
| 5 | 25,209,447 | Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration. | Arthritis Res Ther | 2014 | https://conductscience.org/library/papers/25209447 | PubMed |
| 6 | 10,436,276 | Neovascularization of the outermost area of herniated lumbar intervertebral discs. | J Orthop Sci | 1999 | https://conductscience.org/library/papers/10436276 | PubMed |
| 7 | 25,557,915 | Low level light therapy modulates inflammatory mediators secreted by human annulus fibrosus cells during intervertebral disc degeneration in vitro. | Photochem Photobiol | 2015 | https://conductscience.org/library/papers/25557915 | PubMed |
| 8 | 34,542,556 | The Role of the Wnt Pathway in VEGF/Anti-VEGF-Dependent Control of the Endothelial Cell Barrier. | Invest Ophthalmol Vis Sci | 2021 | https://conductscience.org/library/papers/34542556 | PubMed |
| 9 | 32,176,817 | Intervertebral Disc Degeneration Is Associated With Aberrant Endplate Remodeling and Reduced Small Molecule Transport. | J Bone Miner Res | 2020 | https://conductscience.org/library/papers/32176817 | PubMed |
| 10 | 34,650,661 | The Regulatory Effect of MicroRNA-101-3p on Disc Degeneration by the STC1/VEGF/MAPK Pathway. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/34650661 | PubMed |
1 to 10 of 123
See all 123 referencesCited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,932,043 | Establishment and evaluation of a rat model of lumbar intervertebral disc degeneration secondary to posterior structural resection. | J Mol Histol | 2026 | https://conductscience.org/library/papers/42932043 | PubMed |
| 42,657,105 | Blood and lymphatic vascular remodeling in intervertebral disc degeneration. | Front Immunol | 2026 | https://conductscience.org/library/papers/42657105 | PubMed |
| 42,389,730 | Resetting the epigenetic clock: cellular senescence and regenerative strategies in intervertebral disc degeneration. | Front Aging | 2026 | https://conductscience.org/library/papers/42389730 | PubMed |
| 42,243,450 | Coronal curvature angle and asymmetrical blood vessel distribution in intervertebral discs from aged cadavers: a pilot study. | Spine Deform | 2026 | https://conductscience.org/library/papers/42243450 | PubMed |
| 41,884,831 | Exploring the mechanisms underlying quercetin, a key component of Achyranthis Bidentatae Radix, against intervertebral disc degeneration. | Front Immunol | 2026 | https://conductscience.org/library/papers/41884831 | PubMed |
| 41,863,700 | A SASP-related four-gene signature associated with intervertebral disc degeneration: integrated bioinformatics analysis and validation of pinocembrin as a therapeutic candidate. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41863700 | PubMed |
| 40,426,248 | M2 macrophages activate the IL-10/JAK2/STAT3 pathway to induce pathological microangiogenesis in the nucleus pulposus exacerbating intervertebral disc degeneration. | J Orthop Surg Res | 2025 | https://conductscience.org/library/papers/40426248 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39205477
GET https://conductscience.org/api/papers/v1/39205477/references?page=2